AAUM (Average Assets Under Management) of ₹4,389.21 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 17.6% | 17.2% | ▼ -0.4% |
| Finance | 7.9% | 10.2% | ▲ +2.3% |
| Aerospace & Defense | 6.3% | 6.1% | ▼ -0.2% |
| Automobiles | 6.0% | 5.8% | ▼ -0.2% |
| Healthcare Services | 6.1% | 5.7% | ▼ -0.4% |
| Retailing | 4.9% | 5.2% | ▲ +0.3% |
| IT - Software | 4.2% | 4.4% | ▲ +0.2% |
| Consumer Durables | 4.4% | 4.3% | ▼ -0.2% |
| Telecom - Services | 4.8% | 4.0% | ▼ -0.7% |
| Industrial Products | 3.4% | 3.9% | ▲ +0.4% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 17.2% | 17.5% | ▲ +0.3% |
| Finance | 10.2% | 10.2% | ● +0.1% |
| Aerospace & Defense | 6.1% | 6.2% | ▲ +0.1% |
| Healthcare Services | 5.7% | 5.8% | ● +0.1% |
| Automobiles | 5.8% | 5.7% | ▼ -0.1% |
| Retailing | 5.2% | 5.4% | ▲ +0.2% |
| Consumer Durables | 4.3% | 5.2% | ▲ +1.0% |
| IT - Software | 4.4% | 4.4% | ● 0.0% |
| Telecom - Services | 4.0% | 4.2% | ▲ +0.1% |
| Pharmaceuticals & Biotechnology | 3.7% | 3.9% | ▲ +0.2% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Molbio Diagnostics Ltd. ₹7.85 Cr |
Healthcare Equipment & Supplies | 0.18% |
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | SRF Limited ₹62.30 Cr |
Chemicals & Petrochemicals | 1.37% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | HDFC Bank Limited ₹244.91 Cr |
Banks | 5.00% | 5.73% | +0.73% |
| 2 | Blue Star Limited ₹97.81 Cr |
Consumer Durables | 1.56% | 2.29% | +0.73% |
| 3 | Krishna Institute Of Medical Sciences Limited ₹113.66 Cr |
Healthcare Services | 2.27% | 2.66% | +0.39% |
| 4 | Piramal Finance Ltd ₹117.38 Cr |
Finance | 2.46% | 2.75% | +0.29% |
| 5 | Dixon Technologies (India) Limited ₹124.84 Cr |
Consumer Durables | 2.69% | 2.92% | +0.23% |
| 6 | Eternal Limited ₹231.20 Cr |
Retailing | 5.21% | 5.41% | +0.20% |
| 7 | Divi's Laboratories Limited ₹164.92 Cr |
Pharmaceuticals & Biotechnology | 3.69% | 3.86% | +0.17% |
| 8 | Bharti Airtel Limited ₹178.16 Cr |
Telecom - Services | 4.04% | 4.17% | +0.13% |
| 9 | UNO Minda Limited ₹129.35 Cr |
Auto Components | 2.90% | 3.03% | +0.13% |
| 10 | Astra Microwave Products Limited ₹123.37 Cr |
Aerospace & Defense | 2.76% | 2.89% | +0.13% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | KEI Industries Limited ₹144.92 Cr |
Industrial Products | 3.85% | 3.39% | -0.46% |
| 2 | Fortis Healthcare Limited ₹132.04 Cr |
Healthcare Services | 3.42% | 3.09% | -0.33% |
| 3 | Shriram Finance Limited ₹199.00 Cr |
Finance | 4.94% | 4.66% | -0.28% |
| 4 | ICICI Bank Limited ₹294.38 Cr |
Banks | 7.12% | 6.89% | -0.23% |
| 5 | State Bank of India ₹209.27 Cr |
Banks | 5.08% | 4.90% | -0.18% |
| 6 | Maruti Suzuki India Limited ₹112.76 Cr |
Automobiles | 2.81% | 2.64% | -0.17% |
| 7 | Radico Khaitan Limited ₹132.69 Cr |
Beverages | 3.23% | 3.11% | -0.12% |
| 8 | Reliance Industries Limited ₹150.01 Cr |
Petroleum Products | 3.55% | 3.51% | -0.04% |
| 9 | Larsen & Toubro Limited ₹100.69 Cr |
Construction | 2.38% | 2.36% | -0.02% |
| 10 | Bharat Electronics Limited ₹140.06 Cr |
Aerospace & Defense | 3.29% | 3.28% | -0.01% |
29 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹294.38 Cr |
Banks |
6.89%
|
|
| 2 |
₹244.91 Cr |
Banks |
5.73%
|
|
| 3 |
₹231.20 Cr |
Retailing |
5.41%
|
|
| 4 |
₹209.27 Cr |
Banks |
4.90%
|
|
| 5 |
₹199.00 Cr |
Finance |
4.66%
|
|
| 6 |
₹178.16 Cr |
Telecom - Services |
4.17%
|
|
| 7 |
₹164.92 Cr |
Pharmaceuticals & Biotechnology |
3.86%
|
|
| 8 |
₹150.01 Cr |
Petroleum Products |
3.51%
|
|
| 9 |
₹144.92 Cr |
Industrial Products |
3.39%
|
|
| 10 |
₹140.06 Cr |
Aerospace & Defense |
3.28%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.